Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety of Budesonide Foam in Active Ulcerative Proctitis/Proctosigmoiditis
NCT01349673Phase 3Terminated
- Sponsor
- Valeant Pharmaceuticals
- Start
- May 2011
- Primary completion
- Dec 2014
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of EPI-EE in ulcerative proctitis, ulcerative proctosigmoiditis, sponsored by Valeant Pharmaceuticals. Started May 2011; status: terminated.
02
Drugs
EPI-EE
03
Conditions
ulcerative proctitisulcerative proctosigmoiditis
Beyond the preview
Go deeper on NCT01349673.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01349673.